Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Feb;15(2):165–170. doi: 10.1128/aac.15.2.165

Pharmacology of Cinoxacin in Humans

Henry R Black 1, Karen S Israel 1, Robert L Wolen 1, Gordon L Brier 1, Boyd D Obermeyer 1, Edgar A Ziege 1, James D Wolny 1
PMCID: PMC352627  PMID: 426511

Abstract

Cinoxacin was almost completely absorbed when given orally and was found to be approximately 60 to 70% protein bound. Peak serum concentrations were reached within 2 h, and detectable serum concentrations persisted up to 12 h after administration of 0.25-, 0.5-, and 1-g multiple oral doses. Although food delayed the absorption and caused a 30% reduction in mean peak serum concentrations, the overall 24-h urinary recovery was not significantly altered. Approximately 50 to 55% of the drug was excreted in the urine as unchanged drug. At 12 h, urine concentrations were still above the minimal inhibitory concentration for most common gram-negative urinary pathogens. Cinoxacin was well tolerated when administered to 23 volunteers from 10 to 28 days. Resistance among fecal isolates initially susceptible to cinoxacin was not observed in nine volunteers who were administered 0.5 g every 12 h for 4 to 28 days.

Full text

PDF
165

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson K. E., Collen S., Mårdh P. A. Studies on cinoxacin. 2. Assay of cinoxacin in body fluids and tissues. J Antimicrob Chemother. 1977 Sep;3(5):417–422. doi: 10.1093/jac/3.5.417. [DOI] [PubMed] [Google Scholar]
  2. Burt R. A., Morgan T., Payne J. P., Bonner R. M. Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man. Br J Urol. 1977 Apr;49(2):147–152. doi: 10.1111/j.1464-410x.1977.tb04089.x. [DOI] [PubMed] [Google Scholar]
  3. Carpiniello V. L., Hanno P. M., Malloy T. R., Wein A. J. Management of simple ureterolithotomy closure. Urology. 1977 Oct;10(4):310–311. doi: 10.1016/0090-4295(77)90156-x. [DOI] [PubMed] [Google Scholar]
  4. Colleen S., Andersson K. E., Mårdh P. A. Studies on cinoxacin. 3. Concentrations of cinoxacin in serum, urine and tissues of urological patients. J Antimicrob Chemother. 1977 Nov;3(6):579–584. doi: 10.1093/jac/3.6.579. [DOI] [PubMed] [Google Scholar]
  5. Giamarellou H., Jackson G. G. Antibacterial activity of cinoxacin in vitro. Antimicrob Agents Chemother. 1975 May;7(5):688–692. doi: 10.1128/aac.7.5.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gordon R. C., Regamey C., Kirby W. M. Serum protein binding of the aminoglycoside antibiotics. Antimicrob Agents Chemother. 1972 Sep;2(3):214–216. doi: 10.1128/aac.2.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Griffith R. S., Black H. R. Blood, urine and tissue concentrations of the cephalosporin antibiotics in normal subjects. Postgrad Med J. 1971 Feb;47(Suppl):32–40. [PubMed] [Google Scholar]
  8. Harrison L. H., Cox C. E. Bacteriologic and pharmacodynamic aspects of nalidixic acid. J Urol. 1970 Dec;104(6):903–913. [PubMed] [Google Scholar]
  9. Jones R. N., Fuchs P. C. In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates. Antimicrob Agents Chemother. 1976 Jul;10(1):146–149. doi: 10.1128/aac.10.1.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kurtz S., Turck M. In vitro activity of cinoxacin, an organic acid antibacterial. Antimicrob Agents Chemother. 1975 Mar;7(3):370–373. doi: 10.1128/aac.7.3.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lumish R. M., Norden C. W. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid. Antimicrob Agents Chemother. 1975 Feb;7(2):159–163. doi: 10.1128/aac.7.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mårdh P. A., Collen S., Andersson K. E. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens. J Antimicrob Chemother. 1977 Sep;3(5):411–416. doi: 10.1093/jac/3.5.411. [DOI] [PubMed] [Google Scholar]
  13. Panwalker A. P., Giamarellou H., Jackson G. G. Efficacy of cinoxacin in urinary tract infections. Antimicrob Agents Chemother. 1976 Mar;9(3):502–505. doi: 10.1128/aac.9.3.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wick W. E., Preston D. A., White W. A., Gordee R. S. Compound 64716, a new synthetic antibacterial agent. Antimicrob Agents Chemother. 1973 Oct;4(4):415–420. doi: 10.1128/aac.4.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES